FMA
CEMI

FNY Managed Accounts’s Chembio diagnostics, Inc. CEMI Stock Holding History

FNY Managed Accounts’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,784
Closed -$17K – 959
2017
Q3 		$17K Buy
+2,784
New +$17.1K 0.02% 382

Other funds holding CEMI

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FNY Managed Accounts's CEMI Position: Q4 2017 in Review

FNY Managed Accounts sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2017, closing a stake of 2,784 shares — an estimated $17K sold.

FNY Managed Accounts first reported a position in CEMI in Q3 2017 and held it in 1 quarter. The position peaked at $17K in Q3 2017. 23 funds tracked by Wall St. Rank hold CEMI as of Q4 2017.

  • FNY Managed Accounts reported no remaining Chembio diagnostics, Inc. position as of Q4 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 2,784 Chembio diagnostics, Inc. shares in Q4 2017, an estimated $17K.
  • FNY Managed Accounts first reported a position in Chembio diagnostics, Inc. in Q3 2017 and held it in 1 quarter.
  • FNY Managed Accounts's Chembio diagnostics, Inc. position peaked at $17K in Q3 2017.
  • 23 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2017.

Based on FNY Managed Accounts's 13F filing for Q4 2017, filed 23 Jan 2018.